tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NRIX Stock Latest News

Nurix Therapeutics price target lowered to $30 from $32 at Oppenheimer
The FlyNurix Therapeutics price target lowered to $30 from $32 at Oppenheimer
11d ago
NRIX
Nurix Therapeutics price target lowered to $16 from $17 at Morgan Stanley
PremiumThe Fly
Nurix Therapeutics price target lowered to $16 from $17 at Morgan Stanley
27d ago
NRIX
Buy Rating for Nurix Therapeutics Driven by Strong Financials and Upcoming Clinical Milestones
PremiumRatings
Buy Rating for Nurix Therapeutics Driven by Strong Financials and Upcoming Clinical Milestones
28d ago
NRIX
Nurix Therapeutics price target lowered to $34 from $36 at H.C. Wainwright
PremiumThe Fly
Nurix Therapeutics price target lowered to $34 from $36 at H.C. Wainwright
28d ago
NRIX
Top 3 Trending Stocks, According to Analysts – 7/11/2025
PremiumMarket News
Top 3 Trending Stocks, According to Analysts – 7/11/2025
1M ago
NRIX
RARE
Optimistic Buy Rating for Nurix Therapeutics Amid Regulatory and Strategic Catalysts
PremiumRatingsOptimistic Buy Rating for Nurix Therapeutics Amid Regulatory and Strategic Catalysts
1M ago
NRIX
Nurix Therapeutics price target lowered to $30 from $32 at Oppenheimer
Premium
The Fly
Nurix Therapeutics price target lowered to $30 from $32 at Oppenheimer
1M ago
NRIX
Nurix Therapeutics: Strategic Advancements and Promising Pipeline Drive Buy Rating
Premium
Ratings
Nurix Therapeutics: Strategic Advancements and Promising Pipeline Drive Buy Rating
1M ago
NRIX
Positive Outlook for Nurix Therapeutics: Strong Financials and Promising Clinical Progress Support Buy Rating
PremiumRatings
Positive Outlook for Nurix Therapeutics: Strong Financials and Promising Clinical Progress Support Buy Rating
1M ago
NRIX
Nurix Therapeutics price target lowered to $26 from $30 at UBS
PremiumThe Fly
Nurix Therapeutics price target lowered to $26 from $30 at UBS
1M ago
NRIX
Nurix Therapeutics Reports Increased Revenue Amid Net Loss
PremiumCompany Announcements
Nurix Therapeutics Reports Increased Revenue Amid Net Loss
1M ago
NRIX
Closing Bell Movers: Ultragenyx slumps 25% on UX143 recommendation
PremiumThe Fly
Closing Bell Movers: Ultragenyx slumps 25% on UX143 recommendation
1M ago
KLG
MEI
Nurix Therapeutics reports Q2 EPS (52c), consensus (74c)
PremiumThe FlyNurix Therapeutics reports Q2 EPS (52c), consensus (74c)
1M ago
NRIX
NRIX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
NRIX Earnings this Week: How Will it Perform?
1M ago
NRIX
Nurix announces EMA grant of Orphan Drug Designation for bexobrutideg
Premium
The Fly
Nurix announces EMA grant of Orphan Drug Designation for bexobrutideg
1M ago
NRIX
Promising Clinical Data from Nurix Therapeutics’ BTK Degrader NX-5948 Supports Buy Rating
PremiumRatings
Promising Clinical Data from Nurix Therapeutics’ BTK Degrader NX-5948 Supports Buy Rating
1M ago
NRIX
Nurix Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Nurix Therapeutics management to meet with Oppenheimer
2M ago
NRIX
Promising Developments in Nurix Therapeutics’ BTK Degrader Drive Buy Rating
PremiumRatings
Promising Developments in Nurix Therapeutics’ BTK Degrader Drive Buy Rating
2M ago
NRIX
Nurix Therapeutics Announces Positive Phase 1 Trial Results
PremiumCompany Announcements
Nurix Therapeutics Announces Positive Phase 1 Trial Results
2M ago
8K
NRIX
Nurix Therapeutics presents updated data from ongoing trial of bexobrutideg
PremiumThe FlyNurix Therapeutics presents updated data from ongoing trial of bexobrutideg
2M ago
NRIX
Optimistic Outlook on Nurix Therapeutics: Strategic Partnerships and Financial Gains Drive Buy Rating
Premium
Ratings
Optimistic Outlook on Nurix Therapeutics: Strategic Partnerships and Financial Gains Drive Buy Rating
2M ago
NRIX
Oppenheimer bullish on Nurix as Sanofi opt-in, competitor data derisk STAT6
Premium
The Fly
Oppenheimer bullish on Nurix as Sanofi opt-in, competitor data derisk STAT6
2M ago
SNY
KYMR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >